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Developing Brain as a Target ofToxicity
Patricia M. Rodier
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The human brain forms over an unusually long period compared to other organs. While most of the basic structure is laid down before birth, neuron
proliferation and migration continue in the postnatal period. The blood-brain barrier is not fully developed until the middle of the first year of life. The
number of synaptic connections between neurons reaches a peak around age two and is then trimmed back by about half. Similarly, there is great
postnatal activity in the development of receptors and transmitter systems as well as in the production of myelin. Many of the toxic agents known
to damage the developing brain interfere with one or more of these developmental processes. Those with antimitotic action, such as X-ray and
methyl mercury, have distinctly different effects on structure depending on which neurons are forming at the time of exposure. Vulnerability to
agents that interfere with cell production decreases rapidly over the early postnatal period. Other toxic substances, such as psychoactive drugs and
agents that alter hormone levels, are especially hazardous during synaptogenesis and the development of transmitter systems, and thus continue to
be damaging for years after birth. Still other toxic substances such as lead, seem to have their greatest effects during even later stages of brain
development, perhaps by interfering with the trimming back of connections. Guidelines designed to protect human populations from developmental
neurotoxicity need to take into account the changing sensitivity of the brain as it passes through different developmental stages, as well as the fun-
damental differences in the effects of toxicants on the mature and the developing brain. - Environ Health Perspect 103(Suppl 6):73-76 (1995)
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The nervous system in the adult is often
described as one of the best-protected sys-
tems of the body. It is physically protected
by being encased in bone and chemically
protected by the blood-brain barrier,
which prevents the random passage of
many toxic agents into the brain. It is com-
mon for adults to experience toxic effects
in the body systems most exposed to the
outside world: the gastrointestinal system,
respiratory system, and skin; and in the
internal organs most exposed to blood-
born toxic agents: the liver and kidneys.
Brain effects are relatively rare.
Unfortunately, the developing central
nervous system (CNS) is much more vul-
nerable to injury from toxic agents than
the adult CNS. In fact, ifwe consider con-
genital defects, we see the brain as the
major target oftoxicity. Ifyou try to list all
the causes of birth defects that you know,
you will find that virtually all damage the
nervous system, while most do relatively
little damage to other organs. For example,
consider rubella (1), metals like lead (2)
and methylmercury (3), alcohol (4),
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retinoids (5), and thalidomide (6).
Among these, rubella can cause heart
defects, alcohol causes changes in facial fea-
tures, retinoids cause abnormalities of the
ears and face, and thalidomide causes limb
defects; but CNS effects are seen with each
of these agents, and often at lower doses
than those required to affect other parts of
the body.
To understand why the CNS is so sub-
ject to developmental injury, it is necessary
to have some basic idea of how the CNS
develops and how its development com-
pares to that in other organs. The nervous
system arises from the ectodermal layer of
the germ disc, the flat surface that faces
the amnion. A groove appears along the
midline ofthe disc and the folds on either
side touch and join, creating a tube that is
wide open at the head and tail ends ofthe
embryo. The process of tube formation
begins in what will be the cervical region
and proceeds toward the head and then
the tail. The closure of the tube is usually
described as occurring between day 21 and
26 after conception. Failures ofthe process
are common. About 1 in 1000 births in
the United States exhibits a neural tube
defect. Some of these, like anencephaly,
are rapidly fatal. Others, like spina bifida
occulta, are compatible with life, but lead
to varying degrees ofabnormal innervation
of the lower extremities. Fortunately, a
major cause of neural tube defects has
been discovered recently, and it is hoped
that folic acid supplementation ofthe diet
will prevent many of these defects in the
future (7).
More common still are failures of the
development of the internal structure of
the CNS. Many of the agents we know to
be toxic to the developing CNS act by
interfering with specific developmental
processes. Some important processes are
represented in Figure 1.
Neuron Proliferation
Even before the neural tube closes, neurons
are being formed. The generation of these
critical cells continues throughout gesta-
tion and well into the first year of life.
Unlike cells in many organs, where only a
few cell types are repeated thousands of
times, the CNS is made ofdozens ofdiffer-
ent types of neurons. Typically, a set of
neurons destined to be similar in morphol-
ogy and function is generated in a short
period, sometimes as little as a few weeks
or even a few days of gestation. Large
motor neurons, like those that stimulate
muscles, are produced first, followed by
sensory neurons. Nuclear groups in the
brain stem and diencephalon tend to form
early, while complex layered structures like
the cerebral cortex, hippocampus, and
cerebellum add cells over a long period (8).
In many structures of the CNS, cell pro-
duction creates numbers of neurons in
excess of the number actually needed, and
the proliferation period is followed by a
wave of cell death that establishes the
proper final number ofneurons (see below).
The first panel of Figure 1 depicts the
neural tube with cells on its inner surface
dividing. Some divisions add more cells to
the generative population, while others
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Figure 1. Developmental processes.
produce cells that leave the mitotic cycle
and become definitive neurons. An insult
to cell proliferation affects only the particu-
lar types forming in its presence. Thus,
agents with this action have very different
effects on brain development when they
are delivered at different stages. They can
reduce the number ofa few cell types and
leave many other groups, formed before or
after the injury, apparently normal (9).
Environmental agents with the property of
killing neurons as they are born include
ionizing radiation (10) and methylmercury
(11,12).
Obviously, cell proliferation occurs in
all parts ofthe body. Yet, even agents that
interfere with all cell production seem to
injure the CNS more than other organs.
This may be because the production of
unique units is a constant feature of CNS
development, while other organ systems
tend to acquire all their basic cell types
early, with subsequent growth consisting of
increasing the numbers of these cells,
rather than adding new cell types. In addi-
tion, we know that the neuron is a cell type
that proliferates only during development.
Whereas many tissues retain the capacity to
add cells throughout life, any loss of neu-
rons is permanent.
Cell Migration
The second panel shows that neurons may
travel from their place of origin to their
final positions in the nervous system. In
structures like the cerebral cortex, where
cells are born on the inner surface of the
neural tube and then move to the outer
surface, the distances traveled can be sub-
stantial. Cell migration does not proceed at
a constant rate throughout development.
Like cell proliferation, it occurs in waves
associated with different cell types. Most
migration occurs early in gestation, when
distances within the brain are small. The
long migrations ofsmall cells of the cere-
bral cortex, hippocampus, and cerebellum
continue for several months after birth.
Occasional neurons in the wrong loca-
tion occur in normal brains, but patches of
misplaced neurons are characteristic only
of brains with serious developmental
injuries. Because toxic agents that lead to
migration failure are often known to inter-
fere with proliferation as well, it has been
difficult to determine whether there are
agents that affect migration exclusively, or
whether migration failures result when cells
are lost, changing the environment of the
cells that form later. Ionizing radiation
(13) and methylmercury (14,15) provide
examples ofthe dual effect on cell survival
and migration. In any case, neurons that
are out ofposition cannot make the proper
connections with the neurons that should
be their neighbors, so they cannot develop
normal function.
Synaptogenesis
To achieve mature function as transmitters
ofsignals, neurons must form connections.
This requires the development ofspecial-
ized structures on the surfaces ofthe send-
ing and receiving neurons. The point of
contact is a synapse. A typical large neuron
is covered with thousands of these.
Research indicates that receptors appear on
large groups of like cells simultaneously,
and release of appropriate transmitters
from cells projecting into the region fol-
lows soon after. Classic causes ofdeficient
synaptogenesis are malnutrition (16) and
hypothyroidism (17). Lead also interferes
with the process ofsynaptogenesis (18).
While neurons retain the ability to
make new synapses throughout life, the
developmental period is critical for the for-
mation ofthe basic circuitry ofthe nervous
system. In addition, many lines ofevidence
suggest that some ofthe early communica-
tion of neurotransmitters to their receptors
has a developmental purpose, signaling
information for further development,
rather than signaling to control body func-
tions, as in the adult (19). Because ofthis,
messengers that have transient effects in
the adult may have permanent effects in
the developing organism. The result is that
agents that block signals or increase them
can interfere with CNS development.
Environmental Health Perspectives 74DEVELOPING BRAINASA TARGETOFTOXICITY
Our society uses countless numbers of
products designed to affect neural
transmission. These include drugs for
human consumption and drugs directed at
pests. As a class, substances that act as
transmitters or hormones, or which can
mimic the actions ofthese messengers, are
suspect for altering synaptogenesis. Such
agents are likely to disturb CNS develop-
ment. An example is the herbicide TOK
(2,4-dichlorophenyl-p-nitrophenyl ether),
which lowers thyroxin levels. Mice exposed
to TOK prenatally have abnormalities in
many systems, including the CNS (20).
CellDeath
Substantial progress has been made in
understanding how cells die in the normal
course of CNS development. What deter-
mines which cells die has been more
difficult to ascertain. It is likely that one
factor is the number or kind of connec-
tions a neuron has made before the cell
death period. The period ofcell death typ-
ically coincides with the period when con-
nections are actively forming. Whatever
the determining factor, it is clear that nat-
urally occurring cell death is not a passive
process. Rather, the cells are removed in
an aggressive and efficient manner.
Presumably, such action serves to leave the
CNS with an optimal number ofwell-con-
nected neurons. Indications of failure of
the necessary cell loss have been reported
in some brain regions of individuals with
autism (21). On the other hand, the active
removal of cells could go beyond what
is needed.
Transmitters and Receptors
The story ofthe differentiation ofneurons
as message carriers goes beyond the process
of making connections. For example, the
level of activity of a neuron seems to
influence the development of receptors in
the cells to which it projects (22). Further,
the nature ofthe transmitting chemicals a
cell produces appears to be controlled by
the stimulation the cell receives at particular
stages ofdevelopment (23).
When the immature brain is compared
to that ofthe adult, there are striking dif-
ferences in the location and number of
receptors (24). Release ofexcitatory amino
acids is a response to ischemia at all ages,
and contributes substantially to subsequent
cell loss by overstimulating neurons with
appropriate receptors. McDonald and
Johnston have proposed that the remark-
able effects of hypoxia-ischemia on the
developing brain may be due in part to
the rich supply of excitatory amino acid
receptors in the immature tissue (25).
TrinmmingofConnections
Just as cells form in numbers greater than
required by the mature nervous system,
connections form in great excess during
development. The winnowing of these
connections to the needed number is a
longer process than cell death. Thus, we
see very high numbers of connections in
the cerebral cortices ofweanling-age rats
and cats (16,26) and in 2-year-old chil-
dren (27). As with cell death, we assume
that the synapses that disappear are less
useful in some way than those that are
retained. However, we know little about
the process by which some connections are
eliminated and others are preserved. This
process is represented in the last panel of
Figure 1. Recent data on the interaction of
low doses of lead with several processes
involved in transmission at the synapse
have suggested the hypothesis that this
metal may interfere with the process of
synapse trimming by reducing the differ-
ence in level ofactivity between active and
inactive synapses (28).
Myelination
The coating ofaxons by sheets ofglial tis-
sue provides insulation and makes transmis-
sion along the axon more rapid. We know
from many demyelinating diseases in the
adult how important myelin is for CNS
function. A number ofagents are thought
to interfere with the deposition ofmyelin in
the developing brain, and since new waves
of myelin formation continue into adult-
hood, such agents could be hazardous over
an extremelylong period (29).
Developmentofthe
Blood-Brain Barrier
In addition to the sensitive processes just
described, the developing brain is distin-
guished by the absence of a blood-brain
barrier. The development ofthis barrier is
a gradual process beginning in utero and
complete around 6 months after birth in
the human (30). Thus, some toxic agents
that never enter the mature brain enter the
developing brain freely. Examples include
cadmium (31) and monosodium gluta-
mate (32).
In summary, the brain is vulnerable to
agents that interfere with any of the
processes involved in its development.
Because ofthe complexity ofa tissue with
thousands of interconnecting circuits, the
establishment of the mature systems of
neural tissue involves more developmental
processes than those of other tissues.
Because ofthis, there are more opportuni-
ties for injury. Probably the most important
feature ofthe CNS with regard to develop-
mental accidents, however, is the sheer
length oftime over which development of
the CNS proceeds.
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